(Q46438521)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

title

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Tanya Siddiqi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Umar Farooq

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1

Sattva S Neelapu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

24

Jason R Westin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

22

Irit Avivi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

26

Armin Ghobadi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

14

Ian W Flinn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

15

Andre Goy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

4

Lazaros J Lekakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

18

Abhinav Deol

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

2

Frederick L Locke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

34

Lynn Navale

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

39

Jeff Wiezorek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

27

Krishna V Komanduri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

author name string

David B Miklos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Caron A Jacobson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Ira Braunschweig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Olalekan O Oluwole

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Yi Lin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

John M Timmerman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Patrick J Stiff

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Jonathan W Friedberg

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Brian T Hill

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Mitchell R Smith

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Peter McSweeney

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Javier Munoz

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Januario E Castro

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Julio C Chavez

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Ronald Levy

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Eric D Jacobsen

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Thomas E Witzig

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Patrick Reagan

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Adrian Bot

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

John Rossi

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Yizhou Jiang

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Jeff Aycock

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Meg Elias

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

David Chang

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

William Y Go

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

language of work or name

English

0 references

publication date

10 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

The New England Journal of Medicine

6 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

volume

377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

issue

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

page(s)

2531-2544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

6 April 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Transformed follicular non-Hodgkin lymphoma

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Chimeric antigen receptor T cells for sustained remissions in leukemia

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Current concepts in the diagnosis and management of cytokine release syndrome

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Relapsed/refractory diffuse large B-cell lymphoma

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Revised response criteria for malignant lymphoma

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5882485

Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29226797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29226797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Are all chimeric antigen receptors created equal?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29226797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1707447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29226797%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

PubMed publication ID

29226797

1 reference